BBusiness Read More Stock market today: Live updatesNovember 12, 2025 Traders work on the floor of the New York Stock Exchange (NYSE) on November 07, 2025 in New…
MMedication Read More Texas AG Ken Paxton moves to block Tylenol maker dividend amid lawsuit over marketingNovember 7, 2025 Texas Attorney General Ken Paxton has filed a motion to block Kenvue, the maker of Tylenol, from issuing…
MMedication Read More Trump, RFK Jr. and Texas lawsuits slam KenvueNovember 5, 2025 Kenvue, the company that makes Tylenol, is fighting on both the political and scientific fronts. The latest blow…
MMedication Read More Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands dealNovember 3, 2025 Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…
BBusiness Read More Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodiesOctober 24, 2025 Nipocalimab, a first-in-class FcRn blocker being investigated for SjD, met its primary endpoint in the Phase 2 DAHLIAS…
HHealthcare Read More What we know as Johnson & Johnson sued by thousands in UK over talcum powderOctober 16, 2025 Thousands of people are launching a collective legal challenge against healthcare giant Johnson & Johnson (J&J), claiming it…
HHealthcare Read More J&J in talks to acquire Protagonist TherapeuticsOctober 13, 2025 Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current…
HHealthcare Read More Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer caseOctober 7, 2025 In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
HHealthcare Read More Johnson & Johnson’s Shareholder Supremacy In HealthcareSeptember 30, 2025 IRVINE, CALIFORNIA – OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on October 17,…
HHealthcare Read More Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth KnowingSeptember 30, 2025 In the latest close session, Johnson & Johnson (JNJ) was up +1.11% at $179.71. This change outpaced the…
AArtificial intelligence Read More Why the crazy spending of this AI boom isn’t like the dot-com bubbleSeptember 28, 2025 If I hear one more hedge fund oligarch on television tell me that the data center buildout/artificial intelligence…
MMarkets Read More Jim Cramer’s top 10 things to watch in the stock market FridaySeptember 26, 2025 My top 10 things to watch Friday, Sept. 26 1. The S & P 500 opened higher this…